Vimarsana
Biggest News Aggregation in the World

Page 10 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Guidelines Today - Breaking & Trending Today

5 Tips to Manage Heart Health After a Heart Attack - Vimarsana News

5 Tips to Manage Heart Health After a Heart Attack

(BPT) - By Dr. Norman Lepor

5 Tips to Manage Heart Health After a Heart Attack | The Jersey Tomato Press - Vimarsana News

5 Tips to Manage Heart Health After a Heart Attack | The Jersey Tomato Press

(BPT) - By Dr. Norman LeporSponsored by Novartis Pharmaceuticals CorporationDr. Lepor was not compensated for his contributions to this article. If you or a loved one has ever had a cardiovascular …

5 Tips to Manage Heart Health After a Heart Attack - Vimarsana News

5 Tips to Manage Heart Health After a Heart Attack

(BPT) - By Dr. Norman LeporSponsored by Novartis Pharmaceuticals CorporationDr. Lepor was not compensated for his contributions to this article. If you or a loved one has ever had a cardiovascular …

Advocating for Equitable Cancer Care: A Call to Establish Comprehensive Survivorship Programming and Enhance Genetic Testing Discussions - Vimarsana News

Advocating for Equitable Cancer Care: A Call to Establish Comprehensive Survivorship Programming and Enhance Genetic Testing Discussions

/PRNewswire/ -- Two new measurements have been added to the Health Equity Report Card (HERC)—a tool for improving the quality and equity of cancer care. The...

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma - Vimarsana News

Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

/PRNewswire/ -- Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves, today announced the FDA...